Syros Pharmaceuticals, Inc.【SYRS】 減価償却費の推移

機能の使い方
(単位:ドル) 減価償却費 前年比(%)
3Q24 325,000 -46.9%
2Q24 331,000 -49.1%
1Q24 334,000 -47.6%
4Q23 400,000 -42.8%
3Q23 612,000 -7.1%
2Q23 650,000 -1.7%
1Q23 638,000 -6.3%
4Q22 699,000 -6.8%
3Q22 659,000 -5.9%
2Q22 661,000 -3.4%
1Q22 681,000 +2.3%
4Q21 750,000 +2.9%
3Q21 700,000 -0.1%
2Q21 684,000 -1.2%
1Q21 666,000 -1.8%
4Q20 729,000 -12.7%
3Q20 701,000 +20.4%
2Q20 692,000 +17.9%
1Q20 678,000 +31.1%
4Q19 835,000 +93.3%
3Q19 582,000 +42.6%
2Q19 587,000 +56.1%
1Q19 517,000 +33.2%
4Q18 432,000 +10.8%
3Q18 408,000 +4.3%
2Q18 376,000 -1.3%
1Q18 388,000 +6.3%
4Q17 390,000 +15.4%
3Q17 391,000 +24.1%
2Q17 381,000 -
1Q17 365,000 -
4Q16 338,000 -
3Q16 315,000 -